期刊文献+

(E)-1,2-二芳基取代乙烯类化合物的合成及抗血小板聚集活性

Synthesis and anti-platelet aggregation activity of substituted(E)-1,2-diarylethene compounds
下载PDF
导出
摘要 在2-溴苄基膦酸二乙酯结构基础上,合成两个系列(E)-1,2-二芳基取代乙烯类化合物(Ⅴ1-Ⅴ9,Ⅵ1-Ⅵ4),并对所合成的化合物进行抗血小板聚集活性实验。合成了13个未见文献报道的目标化合物,结构经元素分析、红外光谱、核磁共振氢谱、质谱确证。初步生物活性测试表明,多数化合物具有不同程度的抗血小板聚集活性,其中化合物Ⅴ4、Ⅴ9的活性较好。结果表明,(E)-1,2-二芳基取代乙烯类化合物是一类新型的具有潜在价值的抗血小板聚集活性的化合物。 Based on the analysis of the structure of diethyl 2-bromobenzylphosphonate,a series of substituted(E)-1,2-diarylethene compounds(V1-V9,VI1-VI4) were synthesized,and their anti-platelet aggregation activities were evaluated.Their structures were confirmed by 1H NMR,IR and MS.It was found that most of the synthesized compounds possessed the anti-platelet aggregation activities,of which compounds V4 and V9 showed the most potent activities.Substituted(E)-1,2-diarylethene compounds are potentially new candidates as anti-platelet aggregation agents.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2010年第5期419-423,共5页 Journal of China Pharmaceutical University
关键词 (E)-1 2-二芳基取代乙烯类化合物 抗血小板聚集活性 合成 substituted(E)-1 2-diarylethene compounds anti-platelet aggregation activity synthesis
  • 相关文献

参考文献6

  • 1Tanaka N,Goto R,Ito R,et al. [2-(ω-phenylalkyl) phenoxy] alkylamines III: synthesis and selective serotonin-2 receptor binding (2) [J]. Chem Pharm Bull,2000,48(11 ) :1 729 - 1 739.
  • 2倪瑾,蔡灵芝,俞世冲,蔡建明,徐建明,吴秋业.二氢哒嗪酮类化合物的合成及其抗血小板聚集活性研究[J].药学服务与研究,2007,7(3):198-201. 被引量:1
  • 3Kemperman GJ, Stuk TL, Lindenvander JJM. Process for the preparation of asenapine and intermediate products used in said process : WO ,2008003460A1 [P] . 2007-07-03.
  • 4Nicola AC, Francesco B, Roberto P, et al. 2-[(3-Methoxyphenylethyl) phenoxy ] -based ABCB 1 inhibitors : effect of different basic side-chains on their biological properties [J]. J Med Chem, 2008,51(23) :7 602 -7 613.
  • 5Akira N, Masahiro B,Takanobu K, et al. Phenoxy propylamine compounds: US,20020111358 A1[P]. 20024)8-15.
  • 6Bron GVR. Aggreation of blood platelets by adenosine diphosphate and its reversal [ J ]. Nature, 1962,194 ( 4 832 ) : 927 - 929.

二级参考文献8

  • 1Griffett E M,Konnon S M,Kumar A,et al.Effects of 6-[p-(phenylacetylpiperazin-1-yl) phenyl]-4,5-dihydro-3(2H)-pyridazinone(CCI 17810) and aspirin on platelet aggregation and adhesiveness[J].Br J Pharmacol,1981,72(4):697-705.
  • 2YANG Guangming,LIU Liangming,XU Jing,et al.Effects of MCI -154 on vascular reactivity and its mechanisms after hemorrhagic shock in rats[J].J Cardiovasc Pharmacol,2006,47(6):751-757.
  • 3Thompson P E,Manganiello V,Degerman E.Re-discovering PDE3 inhibitors-new opportunities for a long neglected target[J].Curr Top Med Chem,2007,7(4):421-436.
  • 4De Hert S G,Lorsomradee S,Cromheecke S,et al.The effects of levosimendan in cardiac surgery patients with poor left ventricular function[J].Anesth Analg,2007,104(4):766-773.
  • 5Thyes M,Lehmann H D,Gries J,et al.6-Aryl-4,5-dihydro-3(2H)-pyridazinones.A new class of compounds with platelet aggregation inhibiting and hypotensive activities[J].J Med Chem,1983,26(6):800-807.
  • 6Born G V R.Aggregation of blood platelets by adenosine diphosphate and its reversal[J].Nature,1962,194(4832):927-929.
  • 7蒋勤,孙常晟.6-(4-取代苯基)-4,5-二氢-3(2H)-哒嗪酮类化合物的合成及其抑制血小板聚集的作用[J].药学学报,1990,25(8):598-603. 被引量:15
  • 8任海祥,吴秋业,宋炳生.6-(4-取代乙酰氨基苯基)-4,5-二氢-3(2H)-哒嗪酮类化合物的合成及其对血小板聚集的抑制作用[J].华西药学杂志,2004,19(1):19-21. 被引量:2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部